Cytokines and the brain

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 3, 2004, Pages 229-232

  Kempuraj, D ^a   Konstantinidou, A ^b   Boscolo, P ^c   Ferro, F ^c   Di Giannantonio, M ^c   Conti, C M V ^c   Merlitti, D ^c   Petrarca, C ^c   Castellani, M L ^c   Doyle, R ^d   Theoharides, T C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Model Neurology Center   (Greece)

^c UNIVERSITY OF CHIETI   (Italy)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain; Cytokines; Neurology; Psychiatry; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHEMOKINE; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; EPITOPE; GLATIRAMER; GROWTH FACTOR; HYDROCORTISONE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SUCROSE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL MODEL; ANTIGEN RECOGNITION; AUTOIMMUNITY; BLOOD BRAIN BARRIER; CELL ACTIVATION; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; EDITORIAL; GENE OVEREXPRESSION; GENETIC LINKAGE; GLIA; HOST RESISTANCE; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLAMMATION; INTERSTITIAL CYSTITIS; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; MAST CELL; MENTAL DISEASE; MENTAL STRESS; METASTASIS; MICROGLIA; MONONUCLEAR CELL; NERVE DEGENERATION; NERVOUS SYSTEM; NEUROGENIC INFLAMMATION; NEUROLOGIC DISEASE; NEUTROPHIL CHEMOTAXIS; PANIC; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINA GANGLION CELL; SEIZURE; STRESS; UPREGULATION; WEIGHT GAIN;

EID: 8344254424     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700301     Document Type: Editorial

References (51)

1. th ed. Appleton and Lange Stamford Connecticut, p.146.
2. Abbas A.K., A.H. Lichtman and J.S. Pober. 1991. Cells and tissues of the immune system. In Cellular and Molecular Immunology. A.K. Abbas, ed. W.B. Saunders Company Philadelphia, p. 14.
3. Yoshino S., H. Hayashi, S. Taneda, H. Takano, M. Sagai and Y. Mori. 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 15:13
4. + T-cell subsets in the peripheral blood of patients with active pulmonary tuberculosis. Int. J. Immunopathol. Pharmacol. 16:247.
5. He S.C., N. Qiao and W. Sheng. 2003. Neurobehavioral, autonomic nervous function and lymphocyte subsets among aluminum electrolytic workers. Int. J. Immunopathol. Pharmacol. 16:139.
6. Kempuraj D., M. Huang, K. Kandere, W. Boucher, R. Letourneau, A. Athanasiou and T.C. Theoharides. 2003. Azelastine inhibits synthesis and secretion of IL-6, IL-8 and TNF-α, by reducing intracellular calcium ion levels in human umbilical cord blood-derived cultured mast cells. Int. Arch. Allergy Immunol. 132:231.
7. Arena A., B. Enzo, G. Enrico, B. Marco and R. Graziella. 2003. Specific immunotherapy of allergic diseases: a three years perspective observational study. Int. J. Immunopathol. Pharmacol. 16:277.
8. Kempuraj D., J. Donelan, S. Frydas, T. Iezzi, P. Conti, W. Boucher, N. G. Papadoopoulou, B. Madhappan, L. Letourneau, G. Sabatino and T.C. Theoharides. 2004. Interleukin-28 and 29 (IL-28 and IL-29): new cytokines with anti-viral activities. Int. J. Immunopathol. Pharmacol. 17:103.
9. Kempuraj D., S. Frydas, K. Kandere, B. Madhappan, R. Letourneau, S. Christodoulou, W. Boucher, G. Riccioni, P. Conti and T. C. Theoharides. 2003. Interleukin-19 (IL-19) network revisited. Int. J. Immunopathol. Pharmacol. 16:95.
10. Kempuraj D., S. Frydas, P. Conti, K. Kandere, W. Boucher, R. Letourneau, B. Madhappan, S.H. Huang, S. Koreaki, S. Christodoulou and T.C. Theoharides. 2003. Interleukin-25: a new IL-17 family member with growth factor/inflammatory action. Int. J. Immunopathol. Pharmacol. 16:185.
11. Di Gioacchino M., N. Verna, E. Cavalluci, F. Paolini, R. Caruso, M. Grana, C. Schiavone, A. Di Iorio, S. Ramando, M. Reale, R. Paganelli and T. C. Theoharides. 2002. Steroid and antihistamines modulate RANTES release in cultured peripheral blood mononuclear cells of atopic patients. Int. J. Immunopathol. Pharmacol. 15:27.
12. Conti P., M. Reale, R.C. Barbacane, M.L. Castellani and C. Orso. 2002. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol. Lett. 80:105.
13. Biswas S.K. and A. Sodhi. 2002. Effect of monocyte chemoattractant protein-1 on murine bone marrow cells: proliferation, colony forming ability signal transduction pathway involved. Int. J. Immunopathol. Pharmacol. 15:183.
14. Perrella O., M. Perrella, V. Cusumano, U. Ibello, C. Sbreglia, R. De Sena and A. Perrella. 2002. Interleukin-10 and transforming growth factor beta 1 in hepatic fibrosis. Int. J. Immunopathol. Pharmacol. 15:243.
15. v mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 15:249.
16. Theoharides T.C. and D. Cochrane. 2004. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146:1
17. Dhabhar F.S. 2002. Stress-induced augmentation of immune function - the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav. Immun. 16:785.
18. Huang D. Y. Han, M.R. Rani, A. Glabinski, C. Trebst, T. Sorensen, M. Tani, J. Wang, P. Chien, S. O'Bryan, B. Bielecki, Z.L. Zhou, S. Majumder and R.M. Ransohoff. 2000. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 177:52.
19. Pehlivanidis C., M. Fotoulaki, W. Boucher, D. Kempuraj, X. Pang, A. Kostantinidou and T.C. Theoharides. 2002. Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J. Clin. Psychopharmacol. 22:221.
20. Theoharides T.C. 2002. Mast cells and stress. A psychoneuroimmunological perspective. J. Clin. Psychopharmacol. 22:103.
21. Huang M., X. Pang, K. Karalis and T.C. Theoharides. 2003. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in a lipoprotein E knockout mice. Cardiovascular Res. 59:241.
22. Kandere-Grzybowska K., R. Letourneau, D. Kempuraj, J. Donelan, S. Paplowski, W. Boucher, A. Athanassiou and T.C. Theoharides. 2003. IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J. Immunol. 171:4830
23. Chiappini E., M. Peruzzi, L. Galli, G. Calabri and M. de Martine. 2002. Dose-related IL-6 overproduction by phenobarbital-incubated peripheral blood mononuclear cells in a child with anticonvulsant hypersensitivity syndrome. Int. J. Immunopathol. Pharmacol. 15:239.
24. Elenkov I.J. and G.P. Chrousos. 2002. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. N.Y. Acad. Sci. 966:290.
25. Steptoe A., N. Owen, S. Kunz-Ebrecht and V. Mohamed-Ali. 2002. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav. Immun. 16:774.
26. Dunn A.J., J. Wang and T. Ando. 1999. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 461:117.
27. Licinio J. and M.L. Wong. 1999. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol. Psychiatry 4:317.
28. Anisman H. and Z. Merali. 2003. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 35:2.
29. Theoharides T.C. and Konstantinidou. 2003. Antidepressant and risk of cancer: a case of misguided associations and priorities. J. Clin. Psychopharmacol. 23:1
30. O'Brien S.M., L.V. Scott and T.G. Dinan. 2004. Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum. Psychopharmacol. 19:397.
31. Kariagina A., D. Romanenko, S.G. Ren and V. Chesnokova. 2004. Hypothalamic-pituitary cytokine network. Endocrinology 145:104.
32. Mennicken F., R. Maki, E.B. de Souza and R. Quirion. 1999. Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol. Sci. 20:73
33. Wada-Isoe K., Y. Wakutani, K. Urakami and K. Nakashima. 2004. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients. Acta Neurol. Scand. 110:124.
34. Calabresi P.A., L.R. Tranquill, H.F. McFarland and E.P. Cowan. 1998. Cytokine gene expression in cells derived from CSF of multiple sclerosis patients. J. Neuroimmunol. 89:198.
35. Adikari S.B., A. Pettersson, M. Soderstrom, Y.M. Huang and H. Link . 2004. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis. Scand. J. Immunol. 59:600.
36. Iachenecker P., I. Bihler, F. Weber, M. Gottschalk, K.V. Toykaand P. Rieckmann. 2004. Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult. Scler. 10:165.
37. Conti P., D. Kempuraj, K. Kandere, M. Di Gioacchino, R.C. Barbacane, M.L. Castellani, M. Felaco, W. Boucher, R. Letourneau and T.C. Theoharides. IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol. Lett. 86:123.
38. Conti P., D. Kempuraj, S. Frydas, K. Kandere, W. Boucher, R. Letourneau, B. Madhappan, K. Sagimoto, S. Christodoulou and T.C. Theoharides. IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26. Immunol. Lett. 88:171.
39. Jung S., I. Siglienti, O. Grauer, T. Magnus, G. Scarlato and K. Toyka. Induction of IL-10 in rat peritoneal macrophages and dendritic cells by glatiramer acetate. J. Neuroimmunol. 148:63.
40. Theoharides T.C., J.M. Donelan, N. Papadopoulou, J. Cao, D. Kempuraj and P. Conti. 2004. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. (in press).
41. de Boer A.G. and D.D. Brimer. 1998. Cytokines and blood-brain barrier permeability. Progress Brain Res. 115:425.
42. Esposito P., N. Chandler, K. Kandere, S. Basu, S. Jacobson, R. Connolly, D. Tutor and T.C. Theoharides. 2002. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303:1061.
43. Cacquevel M., N. Lebeurrier, S. Cheenne and D. Vivien. 2004. Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 5:529.
44. Michalopoulou M, C. Nikolaou, A. Tavernarakis, NM. Alexandri, M. Rentzos, S. Chatzipanagiotou, C. Cambouri and D. Vassilopoulos. 2004. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non-inflammatory neurological diseases. Immunol. Lett. 94:183.
45. Arosio B., D. Trabattoni, L. Galimberti, P. Bucciarelli, F. Fasano, C. Calabresi, C.L. Cazzullo, C. Vergani, G. Annoni and M. Clerici. 2004. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease. Neurobiol. Aging 25:1009.
46. Zhang Y., A. Hayes, A. Pritchard, U. Thaker, M.S. Haque, H. Lemmon, J. Harris , A. Gumming, J.C. Lambert, M.C. Chartier-Harlin , D. St Glair, T. Iwatsubo, D.M. Mann and CL. Lendon. 2004. Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease. Neurosci. Lett. 362:99.
47. Quintanilla R.A., D.I. Orellana, C. Gonzalez-Billault and R.B. Maccioni. 2004. Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell. Res. 295:245.
48. Brambilla F., L. Bellodi, G. Perna, A. Bertani, A. Panerai and P. Sacerdote. 1994. Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Res. 54:135.
49. Weizman R., N. Laor, Z. Weiner, L. Wolmer and H. Bessler. 1999. Cytokine production in panic disorder patients. Clin. Neuropharmacol. 22:107.
50. Theoharides T.C. 2004. Panic disorder, interstitial cystitis, and mast cells. J. Clin. Psychopharmacol. 24:361.
51. Theoharides T.C. and G.R. Sant. 2004. Immunomodulators for the treatment of interstitial cystitis. Urology (in press).